Simple in vitro assays to identify amyloid-β aggregation blockers for Alzheimer's disease therapy

Journal of Alzheimer's Disease

Volumn 19, Issue 4, 2010, Pages 1359-1370

  Guo, Jian Ping ^a   Yu, Sheng ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blueberry; Cinnamon; Congo red; Epigallocatechin gallate; Garlic; Ginger; Resveratrol; Rhubarb; S diclofenac; Senile plaques; Spirulina; Turmeric

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BLUEBERRY EXTRACT; CARYOPHYLLENE; CINNAMON EXTRACT; CURCUMIN; DICLOFENAC; EMODIN; EPIGALLOCATECHIN GALLATE; GARLIC EXTRACT; GINGER EXTRACT; GINKGOLIDE A; GLUCOSE PENTAGALLATE; HOMOTAURINE; INOSITOL; INOSITOL DERIVATIVE; RESVERATROL; RHAMNOSE; RHEIN; RHUBARB EXTRACT; TURMERIC; VALPROIC ACID;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; DRUG PROTEIN BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; SPIRULINA; TRANSGENIC MOUSE;

EID: 77950345575     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1331     Document Type: Article

References (48)

1. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110, 1129-1134.
2. St George-Hyslop PH, Petit A (2005) Molecular biology and genetics of Alzheimer's disease. Comptes Rendus Biologies 328, 119-130.
3. Hutton M (2001) Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. Neurology 56, S21-S25.
4. Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM (2007) Genetically augmenting tau levels does not modulate the onset or progression ofAbeta pathology in transgenic mice. J Neurochem 102, 1053-1063.
5. Samura E, Shoji M, Kawarabayashi T, Sasaki A, Matsubara E, Murakami T, Wuhua X, Tamura S, Ikeda M, Ishiguro K, Saido TC,Westaway D, St George Hyslop P, Harigaya Y, Abe K (2006) Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1. Brain Res 1094, 192-199.
6. Adlard PA, James SA, Bush AI, Masters CL (2009) beta- Amyloid as a molecular therapeutic target in Alzheimer's disease. Drugs Today (Barc) 45, 293-304.
7. Bandiera T, Lansen J, Post C, Varasi M (1997) Inhibitors of A beta peptide aggregation as potential anti-Alzheimer agents. Curr Med Chem 4, 159-170.
8. Estrada LD, Soto C (2006) Inhibition of protein misfolding and aggregation by small rationally-designed peptides. Curr Pharm Des 12, 2557-2567.
9. Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ (2009) A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol 66, 190-199.
10. Steinerman JR, Irizarry M, Scarmeas N, Raju S, Brandt J, Albert M, Blacker D, Hyman B, Stern Y (2008) Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol 65, 906-912.
11. Hellstrom-Lindahl E, Viitanen M, Marutle A (2009) Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease. Neurochem Int 55, 243-252.
12. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM (2008) Amyloidbeta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224.
13. Guo JP, Petric M, Campbell W, McGeer PL (2004) SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 324, 251-256.
14. Giulian D, Haverkamp LJ, Yu J, Karshin W, Tom D, Li J, Kazanskaia A, Kirkpatrick J, Roher AE (1998) The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J Biol Chem 273, 29719-29726.
15. Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL, Murphy RM (1999) Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry 38, 3570-3578.
16. Sigurdsson EM, Permanne B, Soto C, Wisniewski T, Frangione B (2000) In vivo reversal of amyloid-beta lesions in rat brain. J Neuropathol Exp Neurol 59, 11-17.
17. Liu R, Yuan B, Emadi S, Zameer A, Schulz P, McAllister C, Lyubchenko Y, Goud G, Sierks MR (2004) Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity. Biochemistry 43, 6959-6967.
18. Fujiwara H, Tabuchi M, Yamaguchi T, Iwasaki K, Furukawa K, Sekiguchi K, Ikarashi Y, Kudo Y, Higuchi M, Saido TC, Maeda S, Takashima A, Hara M, Yaegashi N, Kase Y, Arai H (2009) A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloylbeta- D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo. J Neurochem 109, 1648-1657.
19. Roberts BE, Shorter J (2008) Escaping amyloid fate. Nat Struct Mol Biol 15, 544-546.
20. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A,Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, offpathway oligomers. Nat Struct Mol Biol 15, 558-566.
21. Rossoni G, Sparatore A, Tazzari V, Manfredi B, Del Soldato P, Berti F (2008) The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br J Pharmacol 153, 100-109.
22. Lee M, Sparatore A, Del Soldato P, McGeer E, McGeer PL (2010) Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 58, 103-113.
23. Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G,Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN (2009) Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 50, 191-197.
24. Frid P, Anisimov SV, Popovic N (2007) Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev 53, 135-160.
25. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32, 981-987.
26. Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280, 37377-37382.
27. Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 54, 111-118.
28. Blanchet J, Longpre F, Bureau G, Morissette M, DiPaolo T, Bronchti G, Martinoli MG (2008) Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 32, 1243-1250.
29. Fenili D, Brown M, Rappaport R, McLaurin J (2007) Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J Mol Med 85, 603-611.
30. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL, Darabie AA, Cousins JE, French JE, Lan MF, Chen F, Wong SS, Mount HT, Fraser PE, Westaway D, St George-Hyslop P (2006) Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12, 801-808.
31. Li XY (2000) Immunomodulating components from Chinese medicines. Pharm Biol 38, 33-40 Suppl. S.
32. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, Investigators GS (2008) Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial. JAMA 300, 2253-2262.
33. Shishodia S, Amin HM, Lai R, Aggarwal BB (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappa B activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70, 700-713.
34. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280, 5892-5901.
35. Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer's betaamyloid fibrils in vitro. J Neurosci Res 75, 742-750.
36. Kim DSHL, Kim JY, Han YS (2007) Alzheimer's disease drug discovery from herbs: Neuroprotectivity from beta-amyloid (1-42) insult. J Altern Complement Med 13, 333-340.
37. Park SY, Kim DSHL (2002) Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod 65, 1227-1231.
38. Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen CH, Zhou W, Wang K, Song W (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205, 2781-2789.
39. Stoppe G, Staedt J (1999) Psychotropic drug treatment of behavioral disorders in dementia. Z Gerontol Geriatr 32, 153-158.
40. Misiti F, Sampaolese B, Mezzogori D, Orsini F, Pezzotti M, Giardina B, Clementi ME (2006) Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic. Brain Res Bull 71, 29-36.
41. Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, Lacombe D, Kong X, Aman A, Laurin J, Szarek WA, Tremblay P (2007) Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging 28, 537-547.
42. Gauthier S, Aisen PS, Ferris SH, Saumier D, Duong A, Haine D, Garceau D, Suhy J, Oh J, Lau W, Sampalis J (2009) Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase Study. J Nutr Health Aging 13, 550-557.
43. Gupta VB, Indi SS, Rao KSJ (2009) Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: relevance to Alzheimer's disease. Phytother Res 23, 111-115.
44. Bermejo-Bescos P, Pinero-Estrada E, del Fresno AMV (2008) Neuroprotection by Spirulina platensis protean extract and phycocyanin against iron-induced toxicity in SH-SY5Y neuroblastoma cells. Toxicol in Vitro 22, 1496-1502.
45. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG (2004) Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 10, 1009-1013.
46. Tung YT, Chua MT, Wang SY, Chang ST (2008) Antiinflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs. Bioresour Technol 99, 3908-3913.
47. Peterson DW, George RC, Scaramozzino F, Lapointe NE, Anderson RA, Graves DJ, Lew J (2009) Cinnamon Extract Inhibits Tau Aggregation Associated with Alzheimer's Disease In Vitro. J Alzheimers Dis 17, 585-597.
48. Castrejon ADR, Elchholz I, Rohn S, Kroh LW, Huyskens-Keil S (2008) Phenolic profile and antioxidant activity of highbush blueberry (Vaccinium corymbosum L.) during fruit maturation and ripening. Food Chem 109, 564-572.